Home NF-κB NF-κB activator TNF-α (31-45), human

research use only

TNF-α (31-45), human NF-κB activator

Cat.No.E7641

TNF-α (31-45), human is a potent activator of NF-kB pathway. It is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and is responsible for a diverse range of signalling events within cells, leading to necrosis or apoptosis. It can be used in research of autoimmune diseases.
TNF-α (31-45), human NF-κB activator Chemical Structure

Chemical Structure

Molecular Weight: 1667.87

Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 1667.87 Formula

C69H122N26O22

 Storage (From the date of receipt)
CAS No. 144796-71-4 Download SDF Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2023-12-11)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05930613 RECRUITING
Recurrent Unexplained Implantation Failure
Assistance Publique - Hôpitaux de Paris
 2023-11-30 PHASE3
NCT07176754 ACTIVE_NOT_RECRUITING
Cardiac Arrest (CA); Post Cardiac Arrest Syndrome
Peking University Third Hospital
 2025-10-01
NCT07344428 NOT_YET_RECRUITING
Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University
 2026-08-01
NCT06812988 ACTIVE_NOT_RECRUITING
Type 1 Diabetes Mellitus
Sanofi
 2025-02-28 PHASE2
NCT07750392 RECRUITING
Myofacial Pain Syndrome
Udayana University
 2026-07-30
NCT04066348 RECRUITING
Tinnitus, Noise Induced
Wayne State University
 2022-07-01 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map